Global and United States Oncology Biosimilars Market Report & Forecast 2022-2028

Global and United States Oncology Biosimilars Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Oncology Biosimilars Product Introduction
1.2 Global Oncology Biosimilars Outlook 2017 VS 2022 VS 2028
1.2.1 Global Oncology Biosimilars Sales in US$ Million for the Year 2017-2028
1.2.2 Global Oncology Biosimilars Sales in Volume for the Year 2017-2028
1.3 United States Oncology Biosimilars Outlook 2017 VS 2022 VS 2028
1.3.1 United States Oncology Biosimilars Sales in US$ Million for the Year 2017-2028
1.3.2 United States Oncology Biosimilars Sales in Volume for the Year 2017-2028
1.4 Oncology Biosimilars Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Oncology Biosimilars in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Oncology Biosimilars Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Oncology Biosimilars Market Dynamics
1.5.1 Oncology Biosimilars Industry Trends
1.5.2 Oncology Biosimilars Market Drivers
1.5.3 Oncology Biosimilars Market Challenges
1.5.4 Oncology Biosimilars Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Oncology Biosimilars Market Segment by Type
2.1.1 Monoclonal Antibody
2.1.2 Hematopoietic Agents
2.1.3 G-CSF
2.1.4 Others
2.2 Global Oncology Biosimilars Market Size by Type
2.2.1 Global Oncology Biosimilars Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Oncology Biosimilars Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Oncology Biosimilars Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Oncology Biosimilars Market Size by Type
2.3.1 United States Oncology Biosimilars Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Oncology Biosimilars Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Oncology Biosimilars Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Oncology Biosimilars Market Segment by Application
3.1.1 Retail Pharmacies
3.1.2 Hospital Pharmacy
3.1.3 Online Pharmacy
3.2 Global Oncology Biosimilars Market Size by Application
3.2.1 Global Oncology Biosimilars Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Oncology Biosimilars Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Oncology Biosimilars Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Oncology Biosimilars Market Size by Application
3.3.1 United States Oncology Biosimilars Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Oncology Biosimilars Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Oncology Biosimilars Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Oncology Biosimilars Competitor Landscape by Company
4.1 Global Oncology Biosimilars Market Size by Company
4.1.1 Top Global Oncology Biosimilars Manufacturers Ranked by Revenue (2021)
4.1.2 Global Oncology Biosimilars Revenue by Manufacturer (2017-2022)
4.1.3 Global Oncology Biosimilars Sales by Manufacturer (2017-2022)
4.1.4 Global Oncology Biosimilars Price by Manufacturer (2017-2022)
4.2 Global Oncology Biosimilars Concentration Ratio (CR)
4.2.1 Oncology Biosimilars Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Oncology Biosimilars in 2021
4.2.3 Global Oncology Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Oncology Biosimilars Manufacturing Base Distribution, Product Type
4.3.1 Global Oncology Biosimilars Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Oncology Biosimilars Product Type
4.3.3 Date of International Manufacturers Enter into Oncology Biosimilars Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Oncology Biosimilars Market Size by Company
4.5.1 Top Oncology Biosimilars Players in United States, Ranked by Revenue (2021)
4.5.2 United States Oncology Biosimilars Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Oncology Biosimilars Sales by Players (2020, 2021 & 2022)
5 Global Oncology Biosimilars Market Size by Region
5.1 Global Oncology Biosimilars Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Oncology Biosimilars Market Size in Volume by Region (2017-2028)
5.2.1 Global Oncology Biosimilars Sales in Volume by Region: 2017-2022
5.2.2 Global Oncology Biosimilars Sales in Volume Forecast by Region (2023-2028)
5.3 Global Oncology Biosimilars Market Size in Value by Region (2017-2028)
5.3.1 Global Oncology Biosimilars Sales in Value by Region: 2017-2022
5.3.2 Global Oncology Biosimilars Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Oncology Biosimilars Market Size YoY Growth 2017-2028
6.1.2 North America Oncology Biosimilars Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Oncology Biosimilars Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Oncology Biosimilars Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Oncology Biosimilars Market Size YoY Growth 2017-2028
6.3.2 Europe Oncology Biosimilars Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Oncology Biosimilars Market Size YoY Growth 2017-2028
6.4.2 Latin America Oncology Biosimilars Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Oncology Biosimilars Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Oncology Biosimilars Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Celltrion
7.1.1 Celltrion Corporation Information
7.1.2 Celltrion Description and Business Overview
7.1.3 Celltrion Oncology Biosimilars Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Celltrion Oncology Biosimilars Products Offered
7.1.5 Celltrion Recent Development
7.2 Biocon
7.2.1 Biocon Corporation Information
7.2.2 Biocon Description and Business Overview
7.2.3 Biocon Oncology Biosimilars Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Biocon Oncology Biosimilars Products Offered
7.2.5 Biocon Recent Development
7.3 Dr. Reddy's Laboratories
7.3.1 Dr. Reddy's Laboratories Corporation Information
7.3.2 Dr. Reddy's Laboratories Description and Business Overview
7.3.3 Dr. Reddy's Laboratories Oncology Biosimilars Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Dr. Reddy's Laboratories Oncology Biosimilars Products Offered
7.3.5 Dr. Reddy's Laboratories Recent Development
7.4 STADA Arzneimittel AG
7.4.1 STADA Arzneimittel AG Corporation Information
7.4.2 STADA Arzneimittel AG Description and Business Overview
7.4.3 STADA Arzneimittel AG Oncology Biosimilars Sales, Revenue and Gross Margin (2017-2022)
7.4.4 STADA Arzneimittel AG Oncology Biosimilars Products Offered
7.4.5 STADA Arzneimittel AG Recent Development
7.5 Intas Pharmaceuticals
7.5.1 Intas Pharmaceuticals Corporation Information
7.5.2 Intas Pharmaceuticals Description and Business Overview
7.5.3 Intas Pharmaceuticals Oncology Biosimilars Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Intas Pharmaceuticals Oncology Biosimilars Products Offered
7.5.5 Intas Pharmaceuticals Recent Development
7.6 Pfizer
7.6.1 Pfizer Corporation Information
7.6.2 Pfizer Description and Business Overview
7.6.3 Pfizer Oncology Biosimilars Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Pfizer Oncology Biosimilars Products Offered
7.6.5 Pfizer Recent Development
7.7 Sandoz International
7.7.1 Sandoz International Corporation Information
7.7.2 Sandoz International Description and Business Overview
7.7.3 Sandoz International Oncology Biosimilars Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Sandoz International Oncology Biosimilars Products Offered
7.7.5 Sandoz International Recent Development
7.8 Teva Pharmaceutical Industries Ltd
7.8.1 Teva Pharmaceutical Industries Ltd Corporation Information
7.8.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
7.8.3 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Products Offered
7.8.5 Teva Pharmaceutical Industries Ltd Recent Development
7.9 Apotex
7.9.1 Apotex Corporation Information
7.9.2 Apotex Description and Business Overview
7.9.3 Apotex Oncology Biosimilars Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Apotex Oncology Biosimilars Products Offered
7.9.5 Apotex Recent Development
7.10 BIOCAD
7.10.1 BIOCAD Corporation Information
7.10.2 BIOCAD Description and Business Overview
7.10.3 BIOCAD Oncology Biosimilars Sales, Revenue and Gross Margin (2017-2022)
7.10.4 BIOCAD Oncology Biosimilars Products Offered
7.10.5 BIOCAD Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Oncology Biosimilars Industry Chain Analysis
8.2 Oncology Biosimilars Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Oncology Biosimilars Distributors
8.3 Oncology Biosimilars Production Mode & Process
8.4 Oncology Biosimilars Sales and Marketing
8.4.1 Oncology Biosimilars Sales Channels
8.4.2 Oncology Biosimilars Distributors
8.5 Oncology Biosimilars Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Oncology Biosimilars CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Oncology Biosimilars Market Trends
Table 3. Oncology Biosimilars Market Drivers
Table 4. Oncology Biosimilars Market Challenges
Table 5. Oncology Biosimilars Market Restraints
Table 6. Global Oncology Biosimilars Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Oncology Biosimilars Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Oncology Biosimilars Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Oncology Biosimilars Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Oncology Biosimilars Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Oncology Biosimilars Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Oncology Biosimilars Revenue Share by Manufacturer, 2017-2022
Table 13. Global Oncology Biosimilars Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Oncology Biosimilars Sales Share by Manufacturer, 2017-2022
Table 15. Global Oncology Biosimilars Price by Manufacturer (2017-2022) & (US$/Unit)
Table 16. Global Oncology Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Oncology Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Biosimilars as of 2021)
Table 18. Top Players of Oncology Biosimilars in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Oncology Biosimilars Product Type
Table 20. Date of International Manufacturers Enter into Oncology Biosimilars Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Oncology Biosimilars Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Oncology Biosimilars Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Oncology Biosimilars Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Oncology Biosimilars Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Oncology Biosimilars Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Oncology Biosimilars Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Oncology Biosimilars Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Oncology Biosimilars Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Oncology Biosimilars Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Oncology Biosimilars Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Oncology Biosimilars Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Oncology Biosimilars Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Oncology Biosimilars Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Oncology Biosimilars Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Oncology Biosimilars Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Oncology Biosimilars Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Oncology Biosimilars Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Oncology Biosimilars Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Oncology Biosimilars Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Oncology Biosimilars Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Celltrion Corporation Information
Table 43. Celltrion Description and Business Overview
Table 44. Celltrion Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 45. Celltrion Oncology Biosimilars Product
Table 46. Celltrion Recent Development
Table 47. Biocon Corporation Information
Table 48. Biocon Description and Business Overview
Table 49. Biocon Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 50. Biocon Product
Table 51. Biocon Recent Development
Table 52. Dr. Reddy's Laboratories Corporation Information
Table 53. Dr. Reddy's Laboratories Description and Business Overview
Table 54. Dr. Reddy's Laboratories Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 55. Dr. Reddy's Laboratories Product
Table 56. Dr. Reddy's Laboratories Recent Development
Table 57. STADA Arzneimittel AG Corporation Information
Table 58. STADA Arzneimittel AG Description and Business Overview
Table 59. STADA Arzneimittel AG Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 60. STADA Arzneimittel AG Product
Table 61. STADA Arzneimittel AG Recent Development
Table 62. Intas Pharmaceuticals Corporation Information
Table 63. Intas Pharmaceuticals Description and Business Overview
Table 64. Intas Pharmaceuticals Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 65. Intas Pharmaceuticals Product
Table 66. Intas Pharmaceuticals Recent Development
Table 67. Pfizer Corporation Information
Table 68. Pfizer Description and Business Overview
Table 69. Pfizer Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 70. Pfizer Product
Table 71. Pfizer Recent Development
Table 72. Sandoz International Corporation Information
Table 73. Sandoz International Description and Business Overview
Table 74. Sandoz International Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 75. Sandoz International Product
Table 76. Sandoz International Recent Development
Table 77. Teva Pharmaceutical Industries Ltd Corporation Information
Table 78. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 79. Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 80. Teva Pharmaceutical Industries Ltd Product
Table 81. Teva Pharmaceutical Industries Ltd Recent Development
Table 82. Apotex Corporation Information
Table 83. Apotex Description and Business Overview
Table 84. Apotex Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 85. Apotex Product
Table 86. Apotex Recent Development
Table 87. BIOCAD Corporation Information
Table 88. BIOCAD Description and Business Overview
Table 89. BIOCAD Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 90. BIOCAD Product
Table 91. BIOCAD Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Oncology Biosimilars Customers List
Table 95. Oncology Biosimilars Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncology Biosimilars Product Picture
Figure 2. Global Oncology Biosimilars Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Oncology Biosimilars Market Size 2017-2028 (US$ Million)
Figure 4. Global Oncology Biosimilars Sales 2017-2028 (K Units)
Figure 5. United States Oncology Biosimilars Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Oncology Biosimilars Market Size 2017-2028 (US$ Million)
Figure 7. United States Oncology Biosimilars Sales 2017-2028 (K Units)
Figure 8. United States Oncology Biosimilars Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Oncology Biosimilars Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Oncology Biosimilars Report Years Considered
Figure 11. Product Picture of Monoclonal Antibody
Figure 12. Product Picture of Hematopoietic Agents
Figure 13. Product Picture of G-CSF
Figure 14. Product Picture of Others
Figure 15. Global Oncology Biosimilars Market Share by Type in 2022 & 2028
Figure 16. Global Oncology Biosimilars Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Oncology Biosimilars Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Oncology Biosimilars Sales by Type (2017-2028) & (K Units)
Figure 19. Global Oncology Biosimilars Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Oncology Biosimilars Price by Type (2017-2028) & (US$/Unit)
Figure 21. United States Oncology Biosimilars Market Share by Type in 2022 & 2028
Figure 22. United States Oncology Biosimilars Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Oncology Biosimilars Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Oncology Biosimilars Sales by Type (2017-2028) & (K Units)
Figure 25. United States Oncology Biosimilars Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Oncology Biosimilars Price by Type (2017-2028) & (US$/Unit)
Figure 27. Product Picture of Retail Pharmacies
Figure 28. Product Picture of Hospital Pharmacy
Figure 29. Product Picture of Online Pharmacy
Figure 30. Global Oncology Biosimilars Market Share by Application in 2022 & 2028
Figure 31. Global Oncology Biosimilars Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Oncology Biosimilars Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Oncology Biosimilars Sales by Application (2017-2028) & (K Units)
Figure 34. Global Oncology Biosimilars Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Oncology Biosimilars Price by Application (2017-2028) & (US$/Unit)
Figure 36. United States Oncology Biosimilars Market Share by Application in 2022 & 2028
Figure 37. United States Oncology Biosimilars Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Oncology Biosimilars Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Oncology Biosimilars Sales by Application (2017-2028) & (K Units)
Figure 40. United States Oncology Biosimilars Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Oncology Biosimilars Price by Application (2017-2028) & (US$/Unit)
Figure 42. North America Oncology Biosimilars Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 43. North America Oncology Biosimilars Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Oncology Biosimilars Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 47. Europe Oncology Biosimilars Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Oncology Biosimilars Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 54. Asia-Pacific Oncology Biosimilars Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America Oncology Biosimilars Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 66. Latin America Oncology Biosimilars Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa Oncology Biosimilars Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 71. Middle East & Africa Oncology Biosimilars Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. U.A.E Oncology Biosimilars Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Oncology Biosimilars Value Chain
Figure 76. Oncology Biosimilars Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs